Vaxil Bio Ltd.
13F holders, Q2 2024 (June 30)1holders −1
0new positions
1sold out
$0.01avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Vaxil Bio Ltd. in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holder was Carret Asset Management, LLC ($160).
- Company
- Vaxil Bio Ltd.
- CUSIP
- 92243L107
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $42 |
All 13F filers, Q1 2024 → Q2 2024: 6,000 shares sold, net −6,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Carret Asset Management, LLC | 0.00% | No change | 20,000 | $160 |
"% of holder's portfolio" is VAXIL BIO LTD's weight in each manager's 13F, not the share of Vaxil Bio Ltd. the manager owns.